MYARTA Trademark

Trademark Overview


On Wednesday, June 28, 2017, a trademark application was filed for MYARTA with the United States Patent and Trademark Office. The USPTO has given the MYARTA trademark a serial number of 79220174. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, June 7, 2021. This trademark is owned by NOVARTIS AG. The MYARTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, immune system, cardiovascular system, metabolic system, endocrine system, respiratory system, musculoskeletal system and genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular diseases and disorders, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infectious, antiviral and antibiotic preparations
myarta

General Information


Serial Number79220174
Word MarkMYARTA
Filing DateWednesday, June 28, 2017
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, June 7, 2021
Registration Number5592422
Registration DateTuesday, October 30, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the prevention and treatment of diseases and disorders of the nervous system, immune system, cardiovascular system, metabolic system, endocrine system, respiratory system, musculoskeletal system and genitourinary system and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treatment of gastroenterological diseases and disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular diseases and disorders, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; pharmaceutical and biological preparations, namely, anti-fungal, anti-infectious, antiviral and antibiotic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, June 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Trademark Events


Event DateEvent Description
Monday, April 4, 2022NOTIFICATION PROCESSED BY IB
Tuesday, November 23, 2021REFUSAL PROCESSED BY IB
Sunday, June 27, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, June 27, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, February 22, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 7, 2019FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 7, 2019FINAL DISPOSITION PROCESSED
Wednesday, January 30, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 30, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Friday, August 10, 2018NOTIFICATION PROCESSED BY IB
Wednesday, July 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 25, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 25, 2018NOTICE OF PUBLICATION
Thursday, July 12, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 2, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 27, 2018ASSIGNED TO LIE
Monday, February 5, 2018ASSIGNED TO EXAMINER
Friday, January 19, 2018REFUSAL PROCESSED BY IB
Sunday, December 17, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, December 17, 2017REFUSAL PROCESSED BY MPU
Thursday, December 7, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 6, 2017SUSPENSION LETTER WRITTEN
Wednesday, November 29, 2017NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, November 15, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 14, 2017SUSPENSION LETTER WRITTEN
Saturday, November 11, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, November 7, 2017ASSIGNED TO EXAMINER
Tuesday, November 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 6, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 2, 2017SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB